We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diabetic Neuropathy Topical Treatment

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by Irmandade da Santa Casa de Misericordia de Sao Paulo.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00661063
First Posted: April 18, 2008
Last Update Posted: April 18, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Irmandade da Santa Casa de Misericordia de Sao Paulo
April 15, 2008
April 18, 2008
April 18, 2008
April 2008
April 2009   (Final data collection date for primary outcome measure)
pain evaluation by visual analogue scale [ Time Frame: 12 weeks ]
Same as current
No Changes Posted
pain evaluation by amount of rescue medication required [ Time Frame: 12 weeks ]
Same as current
Not Provided
Not Provided
 
Diabetic Neuropathy Topical Treatment
Diabetic Neuropathic Pain Topical Treatment- Comparative Study
Comparative study of efficacy and safety of ketamine, clonidine, mixture of both and placebo in patients with diabetic neuropathic pain
Not Provided
Interventional
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Diabetic Neuropathy
  • Pain
  • Drug: ketamine
    ketamine 150 mcg/g bid
  • Drug: vehicle gel
    bid - 12 weeks
  • Drug: ketamine + clonidine
    ketamine 150mcg/g + clonidine 1% gel bid 12 weeks
  • Drug: clonidine gel 1%
    bid 12 weeks
  • Experimental: K
    drug - ketamine 1% gel
    Intervention: Drug: ketamine
  • Placebo Comparator: P
    vehicle gel
    Intervention: Drug: vehicle gel
  • Experimental: M
    association of ketamine and clonidine gel
    Intervention: Drug: ketamine + clonidine
  • Experimental: C
    clonidine gel
    Intervention: Drug: clonidine gel 1%
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
200
June 2009
April 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diabetes Mellitus type I or II
  • Mono or polyneuropathy
  • Treatment with Tricyclic Antidepressant, Carbamazepine during 3 weeks at least
  • Preserved cognition

Exclusion Criteria:

  • Ulcerative or infection or vesicle lesion in pain site
  • Pregnancy
  • Breast feeding
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Brazil
 
 
NCT00661063
042/2007
Yes
Not Provided
Not Provided
Judymara Lauzi Gozzani PhD, ISCMSP
Irmandade da Santa Casa de Misericordia de Sao Paulo
Not Provided
Principal Investigator: Judymara L Gozzani, Investigator Santa Casa de São Paulo
Irmandade da Santa Casa de Misericordia de Sao Paulo
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP